Company research
COOPER COMPANIES, INC.
CIK 711404Updated Sep 26, 2026
SecurityCOO · NASDAQ · equity
Name history
COOPER COMPANIES INC · through Jun 26, 2019
COO price & chart
Loading TradingView…
NASDAQ:COO on TradingView ↗About the company
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies has a workforce of more than 15,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit www.coopercos.com.
In the news
No coverage from other publishers is available.
Recent filings
4 filing
4 filing
10-Q filing
Results of Operations and Financial Condition · Other Events
Items 2.02, 8.01, 9.01
4 filing
Show 5 more recent filings
10-Q filing
Results of Operations and Financial Condition · Other Events
Items 2.02, 8.01, 9.01
SD filing
SCHEDULE 13G/A - filed by Capital World Investors regarding COOPER COMPANIES, INC.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 12,394,800,000Source | 12,315,200,000Source | 11,658,900,000Source | 11,492,300,000Source |
| Property, Plant and Equipment, NetUSD | 2,079,900,000Source | 1,860,500,000Source | 1,628,800,000Source | 1,413,700,000Source |
| GoodwillUSD | 3,853,400,000Source | 3,838,400,000Source | 3,624,500,000Source | 3,609,700,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 1,586,300,000Source | 1,791,000,000Source | 1,710,300,000Source | 1,885,100,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 110,600,000Source | 107,600,000Source | 120,800,000Source | 138,200,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 829,000,000Source | 717,000,000Source | 609,700,000Source | 557,800,000Source |
| Inventory, NetUSD | 846,000,000Source | 802,700,000Source | 735,600,000Source | 628,700,000Source |
| Assets, CurrentUSD | 2,106,400,000Source | 1,951,500,000Source | 1,704,900,000Source | 1,533,600,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 320,800,000Source | 324,200,000Source | 238,800,000Source | 208,900,000Source |
| Operating Lease, Right-of-Use AssetUSD | 270,900,000Source | 260,700,000Source | 241,500,000Source | 230,100,000Source |
| Other Assets, NoncurrentUSD | 689,200,000Source | 660,600,000Source | 637,100,000Source | 587,900,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 4,155,700,000Source | 4,231,600,000Source | 4,107,900,000Source | 4,317,600,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 21,800,000Source | 21,700,000Source | 5,400,000Source | 5,400,000Source |
| Additional Paid in CapitalUSD | 1,975,500,000Source | 1,921,000,000Source | 1,833,400,000Source | 1,765,500,000Source |
| Retained Earnings (Accumulated Deficit)USD | 7,643,300,000Source | 7,268,400,000Source | 6,876,100,000Source | 6,584,900,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -406,500,000Source | -421,700,000Source | -453,800,000Source | -466,800,000Source |
| Stockholders' Equity Attributable to ParentUSD | 8,238,900,000Source | 8,083,400,000Source | 7,550,800,000Source | 7,174,500,000Source |
| Liabilities and EquityUSD | 12,394,800,000Source | 12,315,200,000Source | 11,658,900,000Source | 11,492,300,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 1,112,800,000Source | 1,022,800,000Source | 969,000,000Source | 1,280,200,000Source |
| Operating Lease, Liability, CurrentUSD | 37,800,000Source | 38,600,000Source | 38,200,000Source | 35,500,000Source |
| Accounts Payable, CurrentUSD | 300,400,000Source | 260,500,000Source | 261,900,000Source | 248,800,000Source |
| Operating Lease, Liability, NoncurrentUSD | 240,500,000Source | 230,800,000Source | 215,600,000Source | 205,500,000Source |
| Deferred Income Tax Liabilities, NetUSD | 93,300,000Source | 96,000,000Source | 101,500,000Source | 149,900,000Source |
| Other Liabilities, NoncurrentUSD | 282,800,000Source | 311,600,000Source | 239,200,000Source | — |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 200,000Source | 200,000Source | 200,000Source | 200,000Source |
| Additional Financial Items | ||||
| Long-term Debt, Excluding Current MaturitiesUSD | 2,455,700,000Source | 2,548,000,000Source | 2,520,400,000Source | 2,347,100,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 377,400,000Source | 375,100,000Source | 367,700,000Source | 346,100,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 70,500,000Source | 75,100,000Source | 62,100,000Source | 54,200,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 120,300,000Source | 117,100,000Source | 60,200,000Source | 33,800,000Source |
| Increase (Decrease) in InventoriesUSD | 46,000,000Source | 59,300,000Source | 105,400,000Source | 40,400,000Source |
| Increase (Decrease) in Accounts PayableUSD | 8,000,000Source | 9,300,000Source | 5,500,000Source | 49,900,000Source |
| Deferred Income Tax Expense (Benefit)USD | 135,200,000Source | 118,900,000Source | 44,700,000Source | 53,900,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 796,100,000Source | 709,300,000Source | 607,500,000Source | 692,400,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -372,900,000Source | -764,600,000Source | -449,000,000Source | -1,831,200,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 362,400,000Source | 421,200,000Source | 392,500,000Source | 242,000,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 24,800,000Source | 30,300,000Source | 13,100,000Source | 16,800,000Source |
| Payments for Repurchase of Common StockUSD | 290,100,000Source | 0Source | 0Source | 78,500,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -425,900,000Source | 39,200,000Source | -173,900,000Source | 1,193,700,000Source |
| Payments of Ordinary Dividends, Common StockUSD | 0Source | 0Source | 3,000,000Source | 3,000,000Source |
| Repayments of Long-term DebtUSD | 3,205,200,000Source | 3,506,800,000Source | 1,953,900,000Source | 561,500,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 2,900,000Source | -13,200,000Source | -17,700,000Source | 42,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 110,600,000Source | 107,700,000Source | 120,900,000Source | 138,600,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 115,100,000Source | 134,800,000Source | 117,500,000Source | 49,100,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 5,600,000Source | 2,900,000Source | -2,300,000Source | -12,900,000Source |
| Additional Financial Items | ||||
| AmortizationUSD | — | 201,200,000Source | 186,200,000Source | 179,500,000Source |
| Share-based Payment Arrangement, ExpenseUSD | 70,500,000Source | 75,100,000Source | 62,100,000Source | 54,200,000Source |
| Amortization of Intangible AssetsUSD | 199,200,000Source | 201,200,000Source | 186,200,000Source | 179,500,000Source |
| DepreciationUSD | 178,200,000Source | 173,900,000Source | 181,500,000Source | 166,600,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | -22,000,000Source |
| GoodwillUSD | 3,853,400,000Source | 3,838,400,000Source | 3,624,500,000Source | 3,609,700,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 0Source | 0Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | 0Source | — | — | 2,300,000Source |
| Impairment of Intangible Assets, Finite-livedUSD | — | 0Source | 0Source | 0Source |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | — | 0Source | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | 191,600,000Source | 190,000,000Source | 118,700,000Source | 89,500,000Source |
| InterestExpenseNonoperatingUSD | 100,000,000Source | 114,300,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | 374,900,000Source | 392,300,000Source | 294,200,000Source | 385,800,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | 385,800,000Source |
| Nonoperating Income (Expense)USD | -16,400,000Source | -9,100,000Source | -14,900,000Source | 25,000,000Source |
| Other Nonoperating Income (Expense)USD | -16,400,000Source | -9,100,000Source | -14,900,000Source | 25,000,000Source |
| Proceeds from Issuance of Long-term DebtUSD | 3,111,100,000Source | 3,524,200,000Source | 2,124,200,000Source | 1,511,000,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 4,092,400,000Source | 3,895,400,000Source | 3,593,200,000Source | 3,308,400,000Source |
| Cost of RevenueUSD | 1,410,300,000Source | 1,299,700,000Source | 1,235,300,000Source | 1,168,800,000Source |
| Selling, General and Administrative ExpenseUSD | 1,627,800,000Source | 1,533,700,000Source | 1,501,200,000Source | 1,342,200,000Source |
| Operating Income (Loss)USD | 682,900,000Source | 705,700,000Source | 533,100,000Source | 507,600,000Source |
| Other Nonoperating Income (Expense)USD | -16,400,000Source | -9,100,000Source | -14,900,000Source | 25,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 566,500,000Source | 582,300,000Source | 412,900,000Source | 475,300,000Source |
| Income Tax Expense (Benefit)USD | 191,600,000Source | 190,000,000Source | 118,700,000Source | 89,500,000Source |
| Net Income (Loss) Attributable to ParentUSD | 374,900,000Source | 392,300,000Source | 294,200,000Source | 385,800,000Source |
| Earnings Per Share, BasicUSD per share | 1.88Source | 1.97Source | 5.94Source | 7.83Source |
| Earnings Per Share, DilutedUSD per share | 1.87Source | 1.96Source | 5.91Source | 7.76Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 199,100,000Source | 198,900,000Source | 49,500,000Source | 49,300,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 200,000,000Source | 200,400,000Source | 49,800,000Source | 49,700,000Source |
| Interest Expense (non-operating)USD | 100,000,000Source | 114,300,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 199,200,000Source | 201,200,000Source | 186,200,000Source | 179,500,000Source |
| Common Stock, Dividends, Per Share, DeclaredUSD per share | — | — | 0.06Source | — |
| Current Income Tax Expense (Benefit)USD | 56,400,000Source | 71,100,000Source | 74,000,000Source | 35,700,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | -22,000,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 0Source | 0Source |
| Gross ProfitUSD | 2,682,100,000Source | 2,595,700,000Source | 2,357,900,000Source | 2,139,600,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -143,000,000Source | -87,100,000Source | -135,700,000Source | 31,400,000Source |
| Interest ExpenseUSD | — | — | 105,300,000Source | 57,300,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | 385,800,000Source |
| Nonoperating Income (Expense)USD | -16,400,000Source | -9,100,000Source | -14,900,000Source | 25,000,000Source |
| Research and Development ExpenseUSD | 172,200,000Source | 155,100,000Source | 137,400,000Source | 110,300,000Source |
Filing attachments
d96045dex991.htm · 8-K · 2025-12-23
EX-99.1 3 d96045dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 PRESS RELEASE CooperCompanies Appoints Walter M Rosebrough, Jr. to its Board of Directors Enters into Cooperation Agreement with Browning West SAN RAMON, Calif., December 23, 2025 - CooperCompanies (Nasdaq: COO), a leading medical device company, announced today that the Company’s Board of Directors (the “Board”) has appointed Walter (Walt) M Rosebrough, Jr. as an independent director, effective as of January 3, 2026. In connectio…
Read attachment ↗